Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

被引:29
|
作者
Aasen, Synnove Nymark [1 ,2 ]
Parajuli, Himalaya [1 ]
Tuyen Hoang [1 ]
Feng, Zichao [1 ,3 ]
Stokke, Krister [1 ]
Wang, Jiwei [1 ,3 ]
Roy, Kislay [1 ]
Bjerkvig, Rolf [1 ,4 ]
Knappskog, Stian [2 ,5 ]
Thorsen, Frits [1 ,4 ,6 ]
机构
[1] Univ Bergen, Kristian Gerhard Jebsen Brain Tumour Res Ctr, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway
[2] Haukeland Hosp, Dept Oncol & Med Phys, Jonas Lies Vei 65, N-5021 Bergen, Norway
[3] Shandong Univ, Brain Sci Res Inst, 44 Wenhuaxi Rd, Jinan 250100, Shandong, Peoples R China
[4] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg
[5] Univ Bergen, Sect Oncol, Dept Clin Sci, N-5020 Bergen, Norway
[6] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Jonas Lies Vei 91, N-5009 Bergen, Norway
关键词
melanoma; brain metastasis; BRAF; MAPK; PI3K; combined treatment; apoptosis; CANCER CELLS; ACQUIRED-RESISTANCE; BUPARLISIB BKM120; BRAIN METASTASIS; DOSE-ESCALATION; IN-VITRO; MEK; APOPTOSIS; EXPRESSION; SURVIVIN;
D O I
10.3390/ijms20174235
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant melanoma is the most aggressive type of skin cancer and is closely associated with the development of brain metastases. Despite aggressive treatment, the prognosis has traditionally been poor, necessitating improved therapies. In melanoma, the mitogen activated protein kinase and the phosphoinositide 3-kinase signaling pathways are commonly altered, and therapeutically inhibiting one of the pathways often upregulates the other, leading to resistance. Thus, combined treatment targeting both pathways is a promising strategy to overcome this. Here, we studied the in vitro and in vivo effects of the PI3K inhibitor buparlisib and the MEK1/2 inhibitor trametinib, used either as targeted monotherapies or in combination, on patient-derived melanoma brain metastasis cell lines. Scratch wound and trans-well assays were carried out to assess the migratory capacity of the cells upon drug treatment, whereas flow cytometry, apoptosis array and Western blots were used to study apoptosis. Finally, an in vivo treatment experiment was carried out on NOD/SCID mice. We show that combined therapy was more effective than monotherapy. Combined treatment also more effectively increased apoptosis, and inhibited tumor growth in vivo. This suggests a clinical potential of combined treatment to overcome ceased treatment activity which is often seen after monotherapies, and strongly encourages the evaluation of the treatment strategy on melanoma patients with brain metastases.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
    Zhang, Yong
    Weng, Qiuyan
    Han, Jinming
    Chen, Jianming
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 675 - 684
  • [22] The role of PI3K/AKT signaling pathway in gallbladder carcinoma
    Wu, Zeyu
    Yu, Xiao
    Zhang, Shuijun
    He, Yuting
    Guo, Wenzhi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4426 - 4442
  • [23] The Ras/Raf/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma
    Meier, F
    Schittek, B
    Busch, S
    Garbe, C
    Smalley, K
    Satyamoorthy, K
    Li, G
    Herlyn, M
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2986 - 3001
  • [24] KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma
    Zhao, Zhirong
    Zhan, Yuanchang
    Jing, Li
    Zhai, Huali
    ONCOLOGY LETTERS, 2022, 23 (06)
  • [25] Interplay between PI3K/AKT pathway and heart disorders
    Ghafouri-Fard, Soudeh
    Sasi, Ali Khanbabapour
    Hussen, Bashdar Mahmud
    Shoorei, Hamed
    Siddiq, Afshan
    Taheri, Mohammad
    Ayatollahi, Seyed Abdulmajid
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (10) : 9767 - 9781
  • [26] Neogambogic acid induces apoptosis of melanoma B16 cells via the PI3K/Akt/mTOR signaling pathway
    Wu, Chunlan
    Wen, Changhui
    He, Jin
    Sun, Zhimin
    Zha, Xushan
    Tang, Dongxin
    ACTA BIOCHIMICA POLONICA, 2020, 67 (02) : 197 - 202
  • [27] Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
    Zhu, Xinbing
    Li, Rongnian
    Wang, Chen
    Zhou, Shuo
    Fan, Yujia
    Ma, Shuang
    Gao, Didi
    Gai, Nian
    Yang, Jing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma
    J R Todd
    L L Scurr
    T M Becker
    R F Kefford
    H Rizos
    Oncogene, 2014, 33 : 236 - 245
  • [29] Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
    Garrett, Joan T.
    Chakrabarty, Anindita
    Arteaga, Carlos L.
    ONCOTARGET, 2011, 2 (12) : 1314 - 1321
  • [30] The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma
    Todd, J. R.
    Scurr, L. L.
    Becker, T. M.
    Kefford, R. F.
    Rizos, H.
    ONCOGENE, 2014, 33 (02) : 236 - 245